TPI Reports Q2 EPS of $0.14

Tianyin Pharmaceutical Co., Inc. TPI announced the financial results for the second quarter of Fiscal Year 2011. Revenue increased 69.6% year over year to $25.3 million from $14.9 million in 2Q FY2010 Operating income increased 69.0% year over year to $5.3 million from $3.2 million in 2Q FY2010 with operating margins at 21.0% and 21.1% respectively. Net Income was $4.4 million, up 69.2% year over year from $2.6 million in 2Q FY2010, with net margins improved to 17.4% from 17.2% in 2Q FY2010. Earnings per share of $0.16 per basic share, or $0.14 per diluted share, up from $0.10 per basic share, or $0.08 per diluted share a year earlier, a gain of 52.5% and 70.9% respectively.